ERBB2 and gastric cancer: In the present study, according to the screening guidelines for GC, a relatively high number of ERBB2-overexpressing UTUCs, with 29.5% scoring 2+ and 12.3% scoring 3+, were detected, in contrast to the relatively low rate of 10.5% of ERBB2-amplified UTUCs in the cohort.